Table 1.
Comparison of clinical features of our patient with the study by Nagashima et al6
| Nagashima et al, PCB cases, n=100 | Nagashima et al, PCB with MFS, n=26 | Our case, n=1 | |
|---|---|---|---|
| Median age, years | 43 | 53 | 18 |
| Male:female | 56:44 | 13:13 | 1:0 |
| Preceding infection, n | |||
| Upper respiratory tract infection | 71 | 18 | 1 |
| Diarrhoea | 30 | 6 | 0 |
| Arm weakness | 29 | 1 | 0 |
| Dysphagia | 17 | 1 | 1 |
| Diplopia | 17 | 7 | 1 |
| Nasal voice | 7 | 3 | 1 |
| Ophthalmoplegia | 55 | 26 | 1 |
| Facial palsy | 64 | 16 | 1 |
| Hyporeflexia/areflexia | 91 | 26 | 1 |
| Ataxia | 43 | 26 | 1 |
| Cerebrospinal fluid albuminocytological dissociation | 42 | 12 | 0 |
MFS = Miller–Fisher syndrome; PCB = pharyngeal-cervical-brachial.